EUR 1.33
(0.0%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 1.22 Million EUR | -8.59% |
2022 | 1.33 Million EUR | -7.72% |
2021 | 1.45 Million EUR | 76.09% |
2020 | 824 Thousand EUR | -42.34% |
2019 | 1.42 Million EUR | 0.0% |
2017 | 43 Thousand EUR | 1333.33% |
2016 | 3000.00 EUR | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q1 | 330.5 Thousand EUR | 4.26% |
2024 Q2 | 330.5 Thousand EUR | 0.0% |
2023 Q4 | 317 Thousand EUR | 0.0% |
2023 FY | 1.22 Million EUR | -8.59% |
2023 Q1 | 295 Thousand EUR | -6.94% |
2023 Q2 | 295 Thousand EUR | 0.0% |
2023 Q3 | 317 Thousand EUR | 7.46% |
2022 Q4 | 317 Thousand EUR | 0.0% |
2022 FY | 1.33 Million EUR | -7.72% |
2022 Q3 | 317 Thousand EUR | -10.07% |
2022 Q2 | 352.5 Thousand EUR | 0.0% |
2022 Q1 | 352.5 Thousand EUR | -17.54% |
2021 FY | 1.45 Million EUR | 76.09% |
2021 Q4 | 427.5 Thousand EUR | 0.0% |
2021 Q3 | 427.5 Thousand EUR | 43.46% |
2021 Q2 | 298 Thousand EUR | 0.0% |
2021 Q1 | 298 Thousand EUR | 27.62% |
2020 FY | 824 Thousand EUR | -42.34% |
2020 Q2 | 178.5 Thousand EUR | 0.0% |
2020 Q1 | 178.5 Thousand EUR | 0.0% |
2020 Q3 | 233.5 Thousand EUR | 30.81% |
2020 Q4 | 233.5 Thousand EUR | 0.0% |
2019 FY | 1.42 Million EUR | 0.0% |
2017 FY | 43 Thousand EUR | 1333.33% |
2016 FY | 3000.00 EUR | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Bluelinea Société Anonyme | 9826.00 EUR | -12356.747% |
Carmat SA | 2.84 Million EUR | 57.022% |
Diagnostic Medical Systems S.A. | 42.15 Million EUR | 97.096% |
Euromedis Groupe | 37.42 Million EUR | 96.73% |
Eurobio Scientific Société anonyme | 130.64 Million EUR | 99.063% |
Ikonisys S.A. | 448.55 Thousand EUR | -172.875% |
Implanet S.A. | 7.44 Million EUR | 83.564% |
Median Technologies SA | 22.22 Million EUR | 94.493% |
SpineGuard SA | 4.31 Million EUR | 71.619% |
Theraclion SA | 1.82 Million EUR | 32.829% |
Euroapi S.A. | 1.01 Billion EUR | 99.88% |
Guerbet SA | 785.69 Million EUR | 99.844% |